 unusually young when it comes to what an insurance company might see as a target demographic to approve screenings. And so I wonder how much of a challenge that may be as we go forward thinking about what to do here. Because if the guideline is for colorectal cancer, for example, screen 45 and after, but we're looking at people in their 30s or possibly even 20s,